ArticleClinical nephrology. Case studies2025
Acute kidney injury after treatment with arsenic trioxide.
Article in Clinical nephrology. Case studies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
All-trans retinoic acid (ATRA) and arsenic trioxide (ATO)-based therapy has become the standard of care in the treatment of acute promyelocytic leukemia (APL). While ATO nephrotoxicity has been rarely reported, data on the specific mechanisms and types of renal injury remain scarce. We present a case of acute kidney injury (AKI) superimposed on chronic kidney disease (CKD) induced by ATO therapy in a patient diagnosed with APL. Biopsy findings revealed acute interstitial nephritis on a background of IgA nephropathy. The AKI resolved after the discontinuation of ATO therapy and initiating steroid treatment. The kidney function remained stable at 6-month follow-up. This case highlights the potential renal complications associated with ATO therapy and highlights the importance of monitoring kidney function in patients undergoing this treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.